Jan Stern Reed - 16 Jul 2025 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Reporting relationship: Director
Issuer ticker: ANGO
Reported as of: 16 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Jul 2025, 18:06:13 UTC
Prior SEC filing: 05 Jun 2025
Next SEC filing: 12 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Lawrence T. Weiss, Attorney in Fact

Key filing fact

Jan Stern Reed filed Form 4 for ANGIODYNAMICS INC (ANGO) on 18 Jul 2025.

Key facts

This page summarizes Jan Stern Reed's Form 4 filing for ANGIODYNAMICS INC (ANGO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Jul 2025, 18:06.

Change

Previous filing in this sequence was filed on 05 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001124181 Primary reporting owner

REED JAN STERN

Relationship: Director
Address: 14 PLAZA DRIVE, LATHAM
Signature: /s/ Lawrence T. Weiss, Attorney in Fact
Signature date: 18 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANGO transaction

Common Stock

Award

Transaction value: $0
Shares: +17,675
Change %: +20%
Price: $0.000000
Shares after: 105,034
Date: 16 Jul 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.

SEC remarks

Exhibit 24.1 - Power of Attorney